Valenta expands its presence outside Russia

| By | Drug Manufacturing, Pharmaceutical Manufacturing, Valenta
0
2156

Valenta continues to expand its presence on the pharmaceutical markets of other countries.

In March 2017, it made the first delivery to Georgia of Ingavirin® 90 mg capsules and Ingavirin® 60 mg capsules intended for use in children aged 7 years and older.

The company also won the tender of the Ministry of Defence of Armenia for the delivery of anti-cold medicines such as Grammidine®NEO, Grammidine®NEO with anesthetic and Ingavirin® 90mg capsules.

Mikhail Tulsky, Sales Director of Valenta Pharm PJSC, said, “The anti-cold portfolio is one of the key portfolios for our company. The focused work with the distributor and representatives of the Ministry of Health, as well as clear development strategy, allowed our company to supply the medicines not only to the commercial market but also to the state amid a tough competition both with Russian companies and international giants.”

SOURCE: gmpnews.ru
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.